Kindling Bio Revenue
Biotechnology Research • 
London, England, United Kingdom • 1-10 Employees
$
Kindling Bio revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Kindling Bio
Jeff Drew
Co-Founder
Company overview
| Headquarters | London, England, United Kingdom |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About Kindling Bio
Kindling Bio puts children affected by cancer first. We are pioneering a gene therapy platform that harnesses the unique strengths of the childhood immune system to eliminate cancer, creating safer and more effective treatments for growing bodies.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Kindling Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Kindling Bio has never raised funding before.
Argentina
United Arab Emirates
New Zealand
Australia
Czechia
United StatesFrequently asked questions
Kindling Bio is located in London, England, GB.
Kindling Bio generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
Kindling Bio has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Kindling Bio was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
Kindling Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
